Home > Products > gp40 & TFRC > Anti-gp40 x Anti-TFRC Bispecific Antibody (IgG-IgG)

Anti-gp40 x Anti-TFRC Bispecific Antibody (IgG-IgG)  (BSIG-164)

Anti-gp40 x Anti-TFRC Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-gp40 and anti-TFRC parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can bind two tumor antigens simultaneously. It is designed for the research of Colon cancer; Ovarian cancer therapy.

Specifications
Targets
gp40 & TFRC
Type
IgG-IgG
Species Reactivity
Human
Target 1
gp40
Host Animal 1
Mouse
Target 2
TFRC
Host Animal 2
Mouse
Application
FuncS; Promising therapeutic agent
Related Disease
Colon cancer; Ovarian cancer
Targets
Target 1
gp40
Alternative Names
gp40; glycoprotein 40; adenocarcinoma-associated antigen
Target 2
TFRC
Gene ID
UniProt ID
Alternative Names
TFRC; transferrin receptor; T9; TR; TFR; p90; CD71; TFR1; TRFR; transferrin receptor protein 1; transferrin receptor (p90, CD71); IMD46

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY
Online Inquiry
Please input "biolabs"(case insensitive) as verification code.
45-1 Ramsey Road, Shirley, NY 11967, USA
Email:
Fax: 1-631-207-8356
Or Call
Tel: 1-631-381-2994
Related products of "gp40 & TFRC"
45-1 Ramsey Road, Shirley, NY 11967, USA 1-631-381-2994 1-631-207-8356
24x7 CUSTOMER SERVICE
Easy access to products and services you need from our library via
powerful searching tools
© 2007 - 2019 Creative-Biolabs All Rights Reserved.
Distributors
To view the contact information for a specific location,
select your country or region: